Cefepime Induced Encephalopathy Mimicking Acute Stroke
Journal of the Korean Neurological Association
;
: 372-375, 2019.
Artículo
en Coreano
| WPRIM
| ID: wpr-766822
ABSTRACT
Cefepime is a fourth-generation cephalosporin, developed in 1994, and is well known for its adverse effects. In 2002, the Food and Drug Administration adjusted the labeling to account for increased risk of seizures, encephalopathy and myoclonus, especially in the setting of renal impairment. Here we present a case of an 86-year-old female, undergoing Cefepime treatment, with encephalopathy mimicking acute stroke.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Convulsiones
/
United States Food and Drug Administration
/
Encefalopatías
/
Accidente Cerebrovascular
/
Mioclonía
Límite:
Anciano
/
Aged80
/
Femenino
/
Humanos
Idioma:
Coreano
Revista:
Journal of the Korean Neurological Association
Año:
2019
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS